Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by n1urrw12on Jun 04, 2014 11:03am

212 Views

Post# 22628821

I think SBM needs to investigate trading

IMO it appears there is constant churning among certain Houses especially TD; Desjardins and Anonymous and the brokers behind these trades are churning accounts for commissions.
It is just to coincidental that day after day there is continious crossing between the same House or Houses.Let it breathe so we can all reap the rewards instead of trading for commissions or half a cent.Just my opinion

Bullboard Posts

Unique Battery Metals opportunity in Quebec